Acrivon Competitors and Similar CompaniesClear all
Acrivon's competitors and similar companies include CARsgen Therapeutics.
 Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline. |  CARsgen Therapeutics CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment. | |
Founding Date | Founding Date 2018 | Founding Date 2014 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Watertown, US HQ Lund, SE | Locations Shanghai, CN HQ Beijing, CN Shanghai, CN Shanghai, CN Bellaire, US |
Employees | Employees 415% increase | Employees 100 |
For sources of this data, please see the company profile
View Company Profiles
CARsgen Therapeutics
HQ
Shanghai, CN
Employees
100
CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.
View company